GlassScriptPhysician profile
Nancy Lazarescu
NPI 1548463227
$1,594.48
in general payments reported to CMS, 2019-2025
29 companies · $61.28 in 2025
The $61.28 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $310 · 2021: $816 · 2022: $119 · 2023: $37.76 · 2025: $61.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $99.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $99.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $306.66 | 2019-2025 | |
| Novo Nordisk INC | $240.80 | 2019-2022 | |
| Lilly USA, LLC | $120.47 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $119.50 | 2019-2022 | |
| Glaxosmithkline, LLC. | $73.00 | 2019-2023 | Shingrix |
| Jazz Pharmaceuticals INC. | $66.81 | 2019-2021 | |
| Amgen INC. | $62.45 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.31 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.41 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $44.25 | 2020 | |
| Janssen Pharmaceuticals, INC | $40.03 | 2021 | |
| Pfizer INC. | $38.25 | 2021 | |
| Radius Health, INC. | $36.01 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $33.31 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $30.86 | 2020-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.11 | 2021 | |
| Portola Pharmaceuticals, LLC | $27.91 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $25.60 | 2019-2020 | |
| Exact Sciences Corporation | $23.37 | 2023 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $18.93 | 2019 | |
| Abbott Laboratories | $18.38 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.95 | 2022 | |
| Astellas Pharma US INC | $17.11 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.58 | 2021 | |
| Seqirus USA INC | $15.29 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $14.51 | 2019 | |
| Amarin Pharma, INC. | $14.23 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $13.66 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $12.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Lazarescu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.